Crizotinib companion diagnostic - Abbott

Drug Profile

Crizotinib companion diagnostic - Abbott

Alternative Names: Abbott ALK test; ALK gene rearrangement diagnostic - Abbott; Vysis ALK Break Apart FISH Probe Kit

Latest Information Update: 06 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Abbott Laboratories
  • Class Diagnostic agents
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Non-small cell lung cancer

Most Recent Events

  • 06 Mar 2017 Launched for Non-small cell lung cancer (Diagnosis) in Taiwan, South Korea, Malaysia, and Japan (unspecified route) before March 2017
  • 06 Mar 2017 No recent reports on development identified - Registered for Non-small cell lung cancer (Diagnosis) in Australia (unspecified route)
  • 30 Aug 2011 Preregistration for Non-small cell lung cancer (diagnosis) in Asia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top